These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 25663689)

  • 1. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
    Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
    J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.
    Toiyama Y; Hur K; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
    Ann Surg; 2014 Apr; 259(4):735-43. PubMed ID: 23982750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer.
    Toiyama Y; Takahashi M; Hur K; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
    J Natl Cancer Inst; 2013 Jun; 105(12):849-59. PubMed ID: 23704278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of serum microRNA-21 in colorectal cancer.
    Menéndez P; Padilla D; Villarejo P; Palomino T; Nieto P; Menéndez JM; Rodríguez-Montes JA
    J Surg Oncol; 2013 Nov; 108(6):369-73. PubMed ID: 23970420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA expression profiles in human colorectal cancers with liver metastases.
    Lin M; Chen W; Huang J; Gao H; Ye Y; Song Z; Shen X
    Oncol Rep; 2011 Mar; 25(3):739-47. PubMed ID: 21174058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis.
    Pizzini S; Bisognin A; Mandruzzato S; Biasiolo M; Facciolli A; Perilli L; Rossi E; Esposito G; Rugge M; Pilati P; Mocellin S; Nitti D; Bortoluzzi S; Zanovello P
    BMC Genomics; 2013 Aug; 14():589. PubMed ID: 23987127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of microRNA-625 is associated with tumor metastasis and poor prognosis in patients with colorectal cancer.
    Lou X; Qi X; Zhang Y; Long H; Yang J
    J Surg Oncol; 2013 Sep; 108(4):230-5. PubMed ID: 23861214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer.
    Zhang Y; He X; Liu Y; Ye Y; Zhang H; He P; Zhang Q; Dong L; Liu Y; Dong J
    Oncol Rep; 2012 Mar; 27(3):685-94. PubMed ID: 22134529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
    Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
    Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of Serum miR-133b and miR-206 Associate with Clinical Outcomes of Progression as Monitoring Biomarkers for Metastasis Colorectal Cancer Patients.
    Wanram S; Klaewkla N; Pinyosri P
    Microrna; 2024; 13(1):56-62. PubMed ID: 38231064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
    Christensen LL; Tobiasen H; Holm A; Schepeler T; Ostenfeld MS; Thorsen K; Rasmussen MH; Birkenkamp-Demtroeder K; Sieber OM; Gibbs P; Lubinski J; Lamy P; ; Laurberg S; Oster B; Hansen KQ; Hagemann-Madsen R; Byskov K; Ørntoft TF; Andersen CL
    Int J Cancer; 2013 Jul; 133(1):67-78. PubMed ID: 23280316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
    Ma Y; Zhang P; Wang F; Zhang H; Yang J; Peng J; Liu W; Qin H
    Gut; 2012 Oct; 61(10):1447-53. PubMed ID: 22052060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of differential miRNA expression with hepatic vs. peritoneal metastatic spread in colorectal cancer.
    Heublein S; Albertsmeier M; Pfeifer D; Loehrs L; Bazhin AV; Kirchner T; Werner J; Neumann J; Angele MK
    BMC Cancer; 2018 Feb; 18(1):201. PubMed ID: 29463215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A microRNA expression signature predicts meningioma recurrence.
    Zhi F; Zhou G; Wang S; Shi Y; Peng Y; Shao N; Guan W; Qu H; Zhang Y; Wang Q; Yang C; Wang R; Wu S; Xia X; Yang Y
    Int J Cancer; 2013 Jan; 132(1):128-36. PubMed ID: 22674195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.
    Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S
    Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
    Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
    Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Combination of Microarray-Based Profiling and Biocomputational Analysis Identified miR331-3p and hsa-let-7d-5p as Potential Biomarkers of Ulcerative Colitis Progression to Colorectal Cancer.
    Chacon-Millan P; Lama S; Del Gaudio N; Gravina AG; Federico A; Pellegrino R; Luce A; Altucci L; Facchiano A; Caraglia M; Stiuso P
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
    Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.
    Wang F; Ma YL; Zhang P; Shen TY; Shi CZ; Yang YZ; Moyer MP; Zhang HZ; Chen HQ; Liang Y; Qin HL
    J Pathol; 2013 Jan; 229(1):12-24. PubMed ID: 22821729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of serum miR-17-5p associated with poor prognosis in patients with hepatocellular carcinoma.
    Zheng J; Dong P; Gao S; Wang N; Yu F
    Hepatogastroenterology; 2013 May; 60(123):549-52. PubMed ID: 23108086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.